Pacific Edge (ASX:PEB, NZE:PEB) said it seeks to raise about NZ$20 million through a share placement and share purchase plan, according to a Friday filing with the New Zealand and Australian bourses.
The offer comprises a NZ$15 million placement of new ordinary shares to selected investors and a NZ$5 million retail offer via a share purchase plan, with Pacific Edge reserving the right to accept oversubscriptions in both components at its discretion, the filing said.
The shares are priced at NZ$0.10 each, representing a premium to the 20-day volume-weighted average price.
The capital raise aims to strengthen Pacific Edge's cash reserves to build on recent clinical and commercial milestones, expand in non-Medicare channels, and work toward restoring Medicare coverage that ceased on April 24 following the implementation of the Local Coverage Determination for Genetic testing for Oncology, the filing added.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。